Sep 6, 2024 · SpeeDx utilises PlexZyme® technology, de-coupling the detection probe from the primer sequence to produce universal probes which can be used across our entire product portfolio. Our …

Founded in 2009, SpeeDx is an Australian-based private company with offices in London and the US, and distributors across Europe. SpeeDx employs a growing number of team members across our …

Improve productivity and streamline laboratory workflow with SpeeDx automation solutions. Flexible operation and programming for sample extraction preparation and/or qPCR reaction set-up.

Please contact SpeeDx for information about offering SpeeDx diagnostics in your clinic or for a list of current pathology clinics where SpeeDx testing is available.

Sep 1, 2023 · SpeeDx Appoints Jeremy Stackawitz as Chief Executive Officer to Drive Global Expansion of its Molecular Diagnostics Solutions Sydney, Australia – October 24th, 2024 – SpeeDx, a leading …

Please contact SpeeDx for information about offering SpeeDx diagnostics in your clinic or for a list of current pathology clinics where SpeeDx testing is available.

PlexZyme® technology offers high performance and reliable qPCR detection and is the driver behind the entire SpeeDx product portfolio. During PlexZyme® qPCR, primers amplify target nucleic acid …

SpeeDx Pty. Ltd. announced an agreement with Cepheid to manufacture their market-leading ResistancePlus® MG tests for use on the GeneXpert ® System. ResistancePlus® MG FleXible is the …

Class-leading PlexPCR® is the engine driving the entire SpeeDx product range, utilising two proprietary technologies: PlexZyme® and PlexPrime®. This technology enables high performance and reliable …

Please contact SpeeDx for information about offering SpeeDx diagnostics in your clinic or for a list of current pathology clinics where SpeeDx testing is available.